期刊文献+

Rho激酶与缺血性脑血管病 被引量:1

Rho kinase and ischemic cerebrovascular disease
原文传递
导出
摘要 缺血性脑血管病可导致严重的神经功能缺损,甚至死亡。Rho激酶是Rho蛋白的重要下游底物,参与血管平滑肌收缩、细胞迁移、炎症细胞浸润以及血管内皮功能障碍等多种生物学效应,在缺血性脑血管病的发生、发展和梗死体积扩大等过程中起着重要作用。Rho激酶抑制剂可有效舒张痉挛血管,减轻局部炎症反应,保护内皮功能,增加缺血区域血流,缩小梗死体积,改善神经功能。 Ischemic cerebrovascular disease may result in severe neurological deficits, and even death. Rho kinase is an important downstream substrate of Rho protein. It involves in multiple biological effects, including vascular smooth muscle Contraction, cell migration, inflammatory cell infiltration and vascular endothelial dysfunction. It plays important roles in the processes of the occurrence, development and expansion of infarct volume in ischemic cerebrovascular disease. Rho kinase inhibitor can effectively relax vascular spasm, reduce local inflammatory response, protect endothelial function, increase blood flow in ischemic region, reduce infarct volume, and improve neurological function.
出处 《国际脑血管病杂志》 北大核心 2009年第8期626-635,共10页 International Journal of Cerebrovascular Diseases
基金 江苏省高校自然科学基础研究项目(08KJD320011)
关键词 RHO相关激酶类 脑缺血 脑血管障碍 rho-associated kinases cerebral ischemia cerebrovascular disorders
  • 相关文献

参考文献100

  • 1Madaule P, Axel R. A novel ras-related gene family. Cell, 1985, 41: 31-40.
  • 2王志,曹秉振.Rho/Rho激酶信号通路与缺血性脑血管病[J].国际脑血管病杂志,2008,16(5):375-379. 被引量:10
  • 3Bustelo XR, Sauzeau V, Berenjeno IM. GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays, 2007, 29: 356-370.
  • 4Matsui T, Amano M, Yamamoto T, et al. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J, 1996, 15: 2208-2216.
  • 5Doran JD, Liu X, Taslimi P, et al. New insights into the structurefunction relationships of Rho-associated kinase: a thermodynamic arid hydrodynamic study of the dimer-to-monomer transition and its kinetic implications. Biochem J, 2004, 384: 255-262.
  • 6Mueller BK, Mack H, Teusch N. Rho kinase, a promising drug target for neurological disorders. Nat Rev Drug Discov, 2005, 4: 387-398.
  • 7Shimokawa H, Takeshita A. Rho-ldnase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol, 2005, 25: 1767-1775.
  • 8Fukui S, Fukumoto Y, Suzuki J, et al. Long-term inhibition of Rhokinase ameliorates diastolic heart failure in hypertensive rats. J Cardiovasc Pharmacol, 2008, 51: 317-326.
  • 9Stavenger RA, Cui H, Dowlell SE, et al. Discovery of aminofurazanazabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activity. J Med Chem, 2007, 50: 2-5.
  • 10Sagara Y, Hirooka Y, Nozoe M, et al. Pressor response induced by central angiotensin II is mediated by activation of Rho/Rho-kinase pathway via ATI receptors. J Hypertens, 2007, 25: 399-406.

二级参考文献76

共引文献46

同被引文献13

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部